When Clarity Saves Lives: Why We Must Stand by Proven Anaphylaxis Emergency Protocols

The Urgency of Simplicity

In the chaos of a life-threatening allergic reaction, clarity is not a luxury; it’s a necessity. For decades, the medical standard was simple: recognizing symptoms, administering epinephrine, and going to the emergency room. These steps were not just medically sound; they were teachable, repeatable, and life-saving.

Recent updates to anaphylaxis guidelines introduce more nuanced decision-making, including risk stratification and shared patient-provider choices. While well-intentioned, this shift risks replacing certainty with hesitation, especially in emergencies where seconds matter.

In September 2009, my sister, Ruthie T. Cornell, suffered a fatal attack of anaphylaxis after being stung by a honeybee. As a child, Ruthie had had insect stings without serious reactions but this time she stopped breathing and fell into a coma.

My layperson’s opinion is that Ruthie was the victim of an anaphylactic "perfect storm": she was a beekeeper, she had an undiagnosed allergy to bee venom, and she did not have a prescription for epinephrine or an epinephrine auto-injector device. She died on September 23rd, 2009.

Furthermore, Ruthie passed away after receiving immediate emergency care. David Cornell, her husband and a licensed physician, was with her when she was stung. He rendered assistance and immediately called 9-1-1. Dave’s call resulted in the High Point paramedics arriving within minutes. Yet they couldn’t save Ruthie.

From the time she was stung until she lost consciousness was a matter of only a very few minutes. That is typical of an acute anaphylactic reaction; everything happens at a terrifying speed. Fear, confusion, and a sense of impending doom are often reported by sufferers of anaphylaxis. Prompt, accurate diagnosis and treatment are vital in all instances.

Every time a life is lost, particularly from stinging insects, I experience many of the same feelings from years ago at my sister’s bedside: hopelessness, powerlessness, and anger. Preventing others from experiencing that same pain is now my highest priority. In allergy emergencies, the threat of a recurring anaphylactic episode remains a critical concern, even after initial treatment appears successful. That’s why sending the patient to the hospital is so important.

The hazards involved in an anaphylactic emergency are plain for me to see. It is my opinion that these new guidelines, while they do allow "nuance, stratification and patient-provider choices" also add something else: risk.

They open the door to dangerous biphasic anaphylactic reactions. Only a hospital has the ways and means to successfully treat any recurrence of life-threatening symptoms.

Anaphylaxis Symptoms from the American College of Asthma, Allergy Immunology, include:

• Trouble breathing
• Hives or swelling
• Tightness of the throat
• Nausea
• Vomiting
• Abdominal pain
• Diarrhea
• Dizziness
• Fainting
• Low blood pressure
• Rapid heartbeat
• Feeling of doom
• Cardiac arrest

Tragically, during a biphasic reaction symptoms can happen again with the same intensity as the preceding attack. Epinephrine is a fast-acting remedy but only temporary. The drug’s initial efficacy is its strength; peak effectiveness fades within minutes.

Supporting Data: Why ED Visits Still Matter

• Food Allergy Research Education (FARE) reports that 1 in 13 children in the U.S. has food allergies, and many are at risk for life-threatening anaphylaxis.
• The Asthma and Allergy Foundation of America (AAFA) emphasizes that epinephrine is the only proven treatment to reduce hospitalization and death from anaphylaxis.
• Biphasic anaphylaxis occurs in 5–15% of cases, with symptoms recurring hours after initial resolution.

If a patient goes to the ER after the administration of epinephrine, they will be safer and better protected from a fatal reaction. But if they don’t, then they increase the risk of a life-threatening outcome.

The New Guidelines: A Risky Trade-Off

The 2023 Joint Task Force Practice Parameter Update suggests that activation of emergency medical services after home epinephrine administration may NOT be required in all cases. This introduces ambiguity into a situation that demands decisiveness. Expecting patients or caregivers to assess severity, weigh risk factors, and decide whether to go to the ER—in the middle of a crisis—is unrealistic and dangerous.

Expert Voices: The Case for Clarity

“Epinephrine is the only proven anaphylaxis treatment to reduce the risk of hospitalization and death.”
— Dr. Tim Dribin, Emergency Medicine Expert, Cincinnati Children’s Hospital Medical Center

“The diagnosis is clinical, with no single sign or symptom being pathognomonic. Lifetime prevalence has been estimated to be 1.6% to 5.1%.”
— 2023 Practice Parameter Update, American Academy of Allergy, Asthma Immunology (AAAAI)

“Guidelines must reflect both the latest evidence and the realities of patient care. We are not just treating conditions—we’re supporting lives.”
— Dr. Shahzad Mustafa, Rochester Regional Health, Rochester, NY.

Why the Previous Protocols Worked

• Immediate action: No second-guessing. Administer epinephrine and seek emergency care.
• Universal understanding: Parents, teachers, and caregivers could follow the steps without medical training.
• Built-in safety net: ER observation helped catch biphasic reactions and complications.

The Danger of Complexity

While the new guidelines may empower some patients—they also risk leaving others behind. In emergencies, complexity breeds indecision and indecision can be fatal.

It is for this reason I disagree with this report’s arguments, intent, and conclusion. If anyone has symptoms of anaphylaxis, they should immediately administer an emergency epinephrine device. And if they do use epinephrine, they should go to the hospital immediately.

Allergy Advocates New York was founded to honor Ruthie through a program of alertness, awareness, and action. Our organization has sought out information based upon accurate data as a means of creating clarity for making choices and responsibility-based decisions. I do not dispute the data presented in the 2023 task force report. The data in this report says that as many as 15% of biphasic reactions occur in anaphylactic emergencies. That might seem low to most people.

The revised guidelines create doubt, uncertainty, and risk for people having a dangerous anaphylactic reaction. People just like my sister Ruthie.

Thanks for reading. Best wishes to one and all from Allergy Advocates New York.

— Jon Terry

Advocacy Groups That Support Emergency Protocols

These organizations actively promote emergency preparedness and education for anaphylaxis:

Food Allergy Research Education (FARE) Advocates for safety and inclusion of individuals with food allergies; promotes emergency preparedness

Asthma and Allergy Foundation of America (AAFA) Provides education and action plans for anaphylaxis; supports ER visits and epinephrine use

Food Allergy Anaphylaxis Connection Team (FAACT) Educates families and schools on managing life-threatening allergies

Allergy Asthma Network (AAN) Focuses on reducing deaths from asthma and allergies through outreach and emergency planning

Allergy Advocates New York Dedicated to preventing anaphylaxis by providing training, advancing legislation, and raising awareness through education for the public and at-risk individuals

References Resources

1. Johns Hopkins Medicine. Anaphylaxis Clinical Pathway. Updated July 2023.
2. Wang J, Lieberman JA, Wallace DV, et al. Anaphylaxis in Practice: A Guide to the 2023 Practice Parameter Update. AAAAI.
3. ACAAI News. New Guidelines Released for Practitioners Treating Anaphylaxis. December 2023. ACAAI News.
4. AAAAI. Patient Advocacy Organizations.
5. ACAAI. Patient Support Organizations.
6. AAFA. Anaphylaxis Action Plan. Emergency Care Guide.